In a clinical study on breast cancer patients, MWA was found to significantly induce increased levels of ICOS+ activated CD4+ T cells and serum IFN-γ, indicating a multifaceted impact on the local and systemic levels beyond coagulation necrosis and protein degeneration (36). The gene discussed is ICOS; the disease is breast carcinoma.